13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001884931
Total reported value
$405.7M
$405.7M
19 檔
48.7%
During the Q4 2025 filing period, Whitefort Capital Management, LP (CIK: 0001884931) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $405.7M across 19 reported positions.
In Q4 2025, Whitefort Capital Management, LP displayed an active expansion posture, initiating 3 new positions and adding to 4 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABUS | Arbutus Biopharma CORP | Stock-Other | 16.41% | -1.12% | — | |
| 2 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 11.76% | -2.70% | -39.98% | |
| 3 | BALY | Bally's CORP | Stock-Other | 8.11% | +1.29% | +43.04% | |
| 4 | MRNA | Moderna Inc | Stock-Healthcare | 7.54% | — | — | |
| 5 | OABI | Omniab Inc | Stock-Other | 6.73% | -0.38% | — | |
| 6 | JOYY | Joyy Inc-adr | Stock-Other | 6.70% | -0.50% | — | |
| 7 | LQDA | Liquidia CORP | Stock-Other | 6.64% | — | +23.92% | |
| 8 | TDAY | USA Today Co Inc | Stock-Other | 6.29% | -2.27% | +33.17% | |
| 9 | GNW | Genworth Financial Inc | Stock-Financials | 5.86% | -0.19% | -31.38% | |
| 10 | CDZI | Cadiz Inc | Stock-Other | 5.72% | -1.66% | — | |
| 11 | SOC | Sable Offshore CORP | Stock-Other | 4.41% | -4.71% | — | |
| 12 | OPK 3.75 01-15-29Bond | Opko Health Inc | Bond | 3.19% | +0.04% | — | |
| 13 | QURE | uniQure N.V. | Stock-Other | 2.81% | -3.17% | EXIT | |
| 14 | GLD | Spdr Gold Shares | ETF-Commodities | 2.74% | -3.10% | EXIT | |
| 15 | SGRY | Surgery Partners Inc | Stock-Other | 2.37% | +0.53% | +61.73% | |
| 16 | OPK | Opko Health Inc | Stock-Other | 1.37% | +0.24% | -13.20% | |
| 17 | VATE | Innovate CORP | Stock-Other | 0.86% | +2.18% | — | |
| 18 | ✓ | Stock-Other | 0.42% | -0.15% | — | ||
| 19 | NNAVW | Nextnav Inc | Stock-Other | 0.09% | -0.09% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BALY | Bally's CORP | +3.7% | +43.04% | Add |
| 2 | LQDA | Liquidia CORP | +2.6% | +23.92% | Add |
| 3 | TDAY | USA Today Co Inc | +1.9% | +33.17% | Add |
| 4 | CDZI | Cadiz Inc | +0.2% | — | Unchanged |
| 5 | NNAVW | Nextnav Inc | 0% | — | Unchanged |
| 6 | OABI | Omniab Inc | — | — | Unchanged |
| 7 | SGRY | Surgery Partners Inc | — | +61.73% | Add |
| 8 | GLD | Spdr Gold Shares | -0.1% | — | Unchanged |
| 9 | VATE | Innovate CORP | -0.2% | — | Unchanged |
| 10 | JOYY | Joyy Inc-adr | -0.3% | — | Unchanged |
| 11 | OPK | Opko Health Inc | -0.9% | -13.20% | Trim |
| 12 | ✓ | -0.9% | — | Unchanged | |
| 13 | OPK 3.75 01-15-29Bond | Opko Health Inc | -1.1% | — | Unchanged |
| 14 | ABUS | Arbutus Biopharma CORP | -1.5% | — | Unchanged |
| 15 | GNW | Genworth Financial Inc | -3.9% | -31.38% | Trim |
| 16 | ROIV | Roivant Sciences Ltd. | -4% | -39.98% | Trim |
| 17 | MRNA | Moderna Inc | — | NEW | New buy |
| 18 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | EXIT | Sold out |
| 19 | SOC | Sable Offshore CORP | — | NEW | New buy |
| 20 | QURE | uniQure N.V. | — | NEW | New buy |
| 21 | IWM | Ishares Russell 2000 ETF | — | EXIT | Sold out |
According to official SEC Form 13F filings, Whitefort Capital Management, LP reported a total U.S. public equity portfolio value of $405.7M across 19 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ABUS, ROIV, BALY) accounted for 48.7% of total reported equity market value during Q4 2025.
Top New Position Initiated
MRNA
市值: $29.5M
Top Position Liquidated / Trimmed
SPY
前期市值: $26.6M
During Q4 2025, Whitefort Capital Management, LP's top holdings by market value included ABUS (16.4%)、ROIV (11.8%)、BALY (8.1%). The largest single position, ABUS, represented 16.4% of total portfolio value.
In Q4 2025, Whitefort Capital Management, LP made 12 total portfolio adjustments, initiating 3 new buys, adding to 4 positions, trimming 3 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.